These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 36824118)

  • 1. Re: Mandhani A. The paradox of why and how in urology! Indian J Urol 2022;38:247-8.
    Tyagi P
    Indian J Urol; 2023; 39(1):81-82. PubMed ID: 36824118
    [No Abstract]   [Full Text] [Related]  

  • 2. Author Reply Re: Mandhani A. The paradox of why and how in urology! Indian J Urol 2022;38:247-8.
    Mandhani A
    Indian J Urol; 2023; 39(1):82-83. PubMed ID: 36824109
    [No Abstract]   [Full Text] [Related]  

  • 3. National bias in citations in urology journals: parochialism or availability?
    Grange RI
    BJU Int; 1999 Oct; 84(6):601-3. PubMed ID: 10510100
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reply to Takeshi Takahashi's Letter to the Editor re: Riccardo Campi, Riccardo Bertolo, Andrea Minervini, European Association of Urology Young Academic Urologists Renal Cancer Working Group. Re: Partial Versus Radical Nephrectomy in Clinical T2 Renal Masses. Klett DE, Tsivian M, Packiam VT, et al. Int J Urol. 2021;28:1149-54. Eur Urol 2021;80;760-2. Partial Nephrectomy for T2 Kidney Cancer Might Violate the Declaration of Helsinki: Re-envisioning the Value of Clinical Research to Foster the Progress of Evidence-based Urology: The Case of Partial Nephrectomy for cT2 Renal Masses.
    Campi R; Bertolo R; Minervini A;
    Eur Urol; 2022 Feb; 81(2):e46-e47. PubMed ID: 34887115
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Riccardo Campi, Riccardo Bertolo, Andrea Minervini, European Association of Urology Young Academic Urologists Renal Cancer Working Group. Re: Partial Versus Radical Nephrectomy in Clinical T2 Renal Masses. Klett DE, Tsivian M, Packiam VT, et al. Int J Urol. 2021;28:1149-54. Eur Urol. 2021;80:760-2: Partial Nephrectomy for T2 Kidney Cancer Might Violate the Declaration of Helsinki.
    Takahashi T
    Eur Urol; 2022 Feb; 81(2):e44-e45. PubMed ID: 34887116
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Abstracts presented at the American Urological Association Annual Meeting: determinants of subsequent peer reviewed publication: C. C. Hoag, D. S. Elterman and A. E. MacNeily. J Urol 2006; 176: 2624-2629. Re: Factors associated with the full publication of studies presented in abstract form at the annual meeting of the American Urological Association: Smith WA, Cancel QV, Tseng TY, Sultan S, Vieweg J, Dahm P. J Urol 2007; 177: 1084-8.
    Autorino R; Di Lorenzo G; D'Armiento M
    J Urol; 2007 Sep; 178(3 Pt 1):1124-5; author reply 1125. PubMed ID: 17640680
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Management of undescended testes: European Association of Urology/European Society for Paediatric Urology Guidelines. J Pediatr Urol 2016;12:335-43.
    Drlík M
    J Pediatr Urol; 2017 Oct; 13(5):553. PubMed ID: 28826657
    [No Abstract]   [Full Text] [Related]  

  • 8. Re: Overuse of Antimicrobial Prophylaxis in Community Practice Urology: M. Mossanen, J. K. Calvert, S. K. Holt, A. C. James, J. L. Wright, J. D. Harper, J. N. Krieger and J. L. Gore J Urol 2015; 193: 543-547.
    Chen X; Dai J
    J Urol; 2015 Aug; 194(2):597-8. PubMed ID: 25958021
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Steven MacLennan, Eilidh Duncan, Ted A. Skolarus, et al. Improving Guideline Adherence in Urology. Eur Urol Focus. In press. https://doi.org/10.1016/j.euf.2021.10.007.
    Montorsi F
    Eur Urol Focus; 2022 Nov; 8(6):1867. PubMed ID: 35153171
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: A critical assessment of the quality of reporting of randomized, controlled trials in the urology literature. C. D. Scales, Jr., R. D. Norris, s. A. Keitz, B. L. Peterson, G. M. Preminger, J. Vieweg and P. Dahm. J Urol 2007; 177: 1090-1095.
    Mesrobian HG
    J Urol; 2008 Jun; 179(6):2488-9; author reply 2489. PubMed ID: 18439625
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Evidence-based medicine in urology: Hope and Peril C. Niederberger J Urol 2009; 181: 1528-1529.
    Routh JC; Nelson CP
    J Urol; 2009 Sep; 182(3):1236-7; author reply 1237. PubMed ID: 19625043
    [No Abstract]   [Full Text] [Related]  

  • 12. Re: Modifying urology residency training: time to speed up or slow down? P. R. Carroll, J Urol 2006; 175: 811-812.
    Stewart A; Bolton J
    J Urol; 2007 Jan; 177(1):406-7. PubMed ID: 17162102
    [No Abstract]   [Full Text] [Related]  

  • 13. Re: Mauro Gacci, Vasileios I. Sakalis, Markos Karavitakis, et al. European Association of Urology Guidelines on Male Urinary Incontinence. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.05.012.
    Lv M; Luo X; Chen Y
    Eur Urol; 2022 Oct; 82(4):e118. PubMed ID: 35961869
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: J. Alfred Witjes, Harman Max Bruins, Richard Cathomas, et al. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. Eur Urol 2020;79:82-104.
    Baldauf A; Koch R; Heberling U; Thomas C; Froehner M
    Eur Urol; 2021 Jan; 79(1):e29. PubMed ID: 32819787
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: COVID-19 and the Urology Match: Perspectives and a Call to ActionA. T. Gabrielson, T. P. Kohn and M. M. Clifton
    Warren CJ; Davis M; Sadeghi-Nejad H
    J Urol; 2020 Oct; 204(4):850-851. PubMed ID: 32459548
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: Medical malpractice in American urology: 22-year national review of the impact of caps and implications for contemporary practice: M. H. Hsieh, A. G. Tan and M. V. Meng J Urol 2008; 179: 1944-1949.
    Loughlin KR
    J Urol; 2008 Dec; 180(6):2720-1; author reply 2721. PubMed ID: 18951585
    [No Abstract]   [Full Text] [Related]  

  • 17. Re: J. Alfred Witjes, Harman Max Bruins, Richard Cathomas, et al. European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines. Eur Urol 2021;79:82-104: Importance of Standardized Pathology Reporting for Urological Cancers in the Implementation of Urology Guidelines.
    Paner GP; Montironi R
    Eur Urol; 2021 Jan; 79(1):e30-e32. PubMed ID: 32873442
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Anticoagulation and Antiplatelet Therapy in Urological Practice: ICUD/AUA Review Paper: D. J. Culkin, E. J. Exaire, D. Green, M. S. Soloway, A. J. Gross, M. R. Desai, J. R. White and D. J. Lightner J Urol 2014; 192: 1026-1034.
    Dahm P; Sultan S; Mustafa R; Morgan R; Falck-Ytter Y;
    J Urol; 2015 Oct; 194(4):1168-9; discussion 1169. PubMed ID: 26142832
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Personal computers and urological research. P.G. Carter et al. Br. J. Urol., 69, 456-459, 1992.
    McKiernan MV
    Br J Urol; 1993 Apr; 71(4):496. PubMed ID: 8500006
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: Börje Ljungberg, Laurence Albiges, Yasmin Abu-Ghanem, et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2022.03.006.
    Wei Y; Zhang R; Lin L
    Eur Urol; 2022 Sep; 82(3):e88. PubMed ID: 35750581
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.